/C O R R E C T I O N -- Prof Terje Pedersen,SEAS Study Principal Investigator & Head of Steering Committee/

London (ots/PRNewswire)

In the news release, "Update on
the SEAS Study" issued on 21 Jul 2008  07:00 GMT, by Prof Terje
Pedersen,SEAS Study Principal Investigator & Head  of Steering
Committee  over PR Newswire, we are advised by a representative  of
the organisation that the following information has been added to the
release:

Satellite coordinates, audio access and URL for webcast:

Satellite:

European Satellite:

AB1 12.5 Deg West

Txp: B6 Lower, Channel 2

DL: 11152.700 V

symbol rate 5.632

FEC 3/4

American Satellite

Domsat:

Galaxy 11 @ 91 degrees west

KU Band: Txp 13, Channel A

DL: 11946.5 H

SYMBOL RATE 5.632

FEC 3/4

Audio access details are as follows:

Telephone number: 0044-207-190-1232

Conference Title: SEAS Study UpDate

Conference ID:  3904345

Please note that the URL to access the live Webcast has
changed from: http://clients.mediaondemand.net/pedersen/live.asx
to: http://clients.mediaondemand.net/pedersen

Complete, corrected release follows:

- Update on the SEAS Study

Satellite coordinates and URL for webcast:
    Satellite:
    European Satellite:
    AB1 12.5 Deg West
    Txp: B6 Lower, Channel 2
    DL: 11152.700 V
    symbol rate 5.632
    FEC 3/4
    American Satellite
    Domsat:
    Galaxy 11 @ 91 degrees west
    KU Band: Txp 13, Channel A
    DL: 11946.5 H
    SYMBOL RATE 5.632
    FEC 3/4
    Audio access details are as follows:
    Telephone number: 0044-207-190-1232
    Conference Title: SEAS Study UpDate
    Conference ID:  3904345

To access the live Webcast please go to:
http://clients.mediaondemand.net/pedersen

Professor Terje Pedersen (Ulleval University Hospital, Oslo,
Norway), lead investigator for the Simvastatin and Ezetimibe in
Aortic Stenosis (SEAS) Study, will provide an update on the study on
Monday the 21st July.

Also present in London will be Sir Richard Peto (Professor of
Medical Statistics and Epidemiology and Co-director of the Clinical
Trials Service Unit, University of Oxford) Professor Rory Collins
(BHF Professor of Medicine and Epidemiology at the University of
Oxford and Co-director of the Clinical Trials Service Unit) and
Professor Ingar Holme, PhD, (Professor of Biostatistics, University
of Oslo and Ulleval University Hospital, Oslo, Norway), SEAS steering
committee statistician.

The London panel will be joined by Professor Eugene Braunwald
(Professor of Medicine at Harvard Medical School) who will
participate via Web link from Boston and Professor Robert M Califf
(Professor of Medicine, Head of Duke Clinical Research, Duke
University) available via phone link.

You are invited to join us at:

The Hilton London Metropole Hotel,

King Suite (3rd Floor, West Wing),

225 Edgware Road, London W2 1JU

When: 21st July at 5.30pm for a 6pm start, BST

There will be a Q&A session after the press announcement. The
Q&A session is only available for members of the media.

Contact:

For further information please call: The SEAS Press Office on
+44-207-413-3423

/C O R R E C T I O N -- Prof Terje Pedersen,SEAS Study Principal Investigator & Head of Steering Committee/

Enterprises

Wirtschaft

Update on the SEAS Study